A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment.

Twenty one patients with severe systemic lupus erythematosus (SLE) were treated with three daily infusions of either 100 mg or 1 g of methylprednisolone on a randomised double blind basis. Nine patients with unsatisfactory outcome subsequently received the alternative therapy. Patients were rated for improvement on a four point scale using individualised criteria. On three occasions patients improved to 'ideal', on 12 there was 'useful' improvement, on 11 the patient remained static, and on four occasions there was deterioration. There was no significant difference between the clinical states after the two doses. The results suggest that any additional benefit of 1 g of methylprednisolone over 100 mg by repeated infusion in the treatment of active SLE is probably not enough to justify the potential hazards and cost involved.

[1]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[2]  D. Isenberg,et al.  Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus. , 1982, Annals of the rheumatic diseases.

[3]  J. Kasdin,et al.  Monthly pulses of methylprednisolone in SLE nephritis. , 1982, The Journal of rheumatology.

[4]  M. Kahaleh,et al.  Pulse corticosteroid therapy for refractory thrombocytopenia in systemic lupus erythematosus. , 1982, The Journal of rheumatology.

[5]  W. Nickey,et al.  Fatal arrhythmia after pulse methylprednisolone therapy. , 1981, Annals of internal medicine.

[6]  L. Espinoza,et al.  Sudden death after methylprednisolone pulse therapy. , 1981, Annals of internal medicine.

[7]  D. Elbaum,et al.  Car wash tachycardia. , 1981, Annals of internal medicine.

[8]  M. D. Freedman,et al.  Anaphylaxis after intravenous methylprednisolone administration. , 1981, JAMA.

[9]  M. Benson,et al.  Methylprednisolone pulse therapy for nonrenal lupus erythematosus. , 1980, Annals of the rheumatic diseases.

[10]  Fessel Wj.  Megadose corticosteroid therapy in systemic lupus erythematosus. , 1980 .

[11]  I. Slotki,et al.  The treatment of lupus nephritis by methyl prednisolone pulse therapy. , 1978, Postgraduate medical journal.

[12]  G. Neild,et al.  Methylprednisolone pulse therapy in the treatment of polyarteritis nodosa. , 1977, Postgraduate medical journal.

[13]  W. Couser,et al.  BENEFICIAL EFFECTS OF METHYLPREDNISOLONE "PULSE" THERAPY IN DIFFUSE PROLIFERATIVE LUPUS NEPHRITIS , 1976, The Lancet.

[14]  L. Berman,et al.  Letter: Acute arthralgia following high-dose intravenous methylprednisolone therapy. , 1974, Lancet.

[15]  H. Paulus,et al.  Pulse Methylprednisolone in Rheumatoid Arthritis , 1985 .

[16]  A. Suchman,et al.  Seizure after pulse therapy with methyl prednisolone. , 1983, Arthritis and rheumatism.

[17]  H. Paulus,et al.  Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. , 1981, Annals of internal medicine.

[18]  W. Fessel.  Megadose corticosteroid therapy in systemic lupus erythematosus. , 1980, The Journal of rheumatology.

[19]  T. Takahashi.  [Erythematosus]. , 1971, Nihon rinsho. Japanese journal of clinical medicine.